Tourmaline Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Tourmaline Bio and other ETFs, options, and stocks.About TRML
Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. It offers the TOUR006.
CEOSandeep C. Kulkarni
CEOSandeep C. Kulkarni
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2021
Founded2021
Employees—
Employees—
TRML Key Statistics
Market cap416.60M
Market cap416.60M
Price-Earnings ratio-5.65
Price-Earnings ratio-5.65
Dividend yield—
Dividend yield—
Average volume352.41K
Average volume352.41K
High today$16.96
High today$16.96
Low today$16.10
Low today$16.10
Open price$16.69
Open price$16.69
Volume248.46K
Volume248.46K
52 Week high$29.79
52 Week high$29.79
52 Week low$11.56
52 Week low$11.56
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own TRML. This list is generated using Robinhood data, and it’s not a recommendation.